Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Personalized Medicine, |
RCV000735366 | SCV000854520 | uncertain significance | Autistic behavior; Specific learning disability; Abnormal basal ganglia morphology; Abnormal globus pallidus morphology; Bilateral basal ganglia lesions; Abnormal substantia nigra morphology; Attention deficit hyperactivity disorder | criteria provided, single submitter | clinical testing | ||
Mendelics | RCV000990163 | SCV001141006 | likely benign | Episodic ataxia type 2 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002536537 | SCV003690400 | likely benign | Inborn genetic diseases | 2021-12-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Genomics, |
RCV003227847 | SCV003924185 | uncertain significance | Episodic ataxia type 2; Spinocerebellar ataxia type 6; Migraine, familial hemiplegic, 1; Developmental and epileptic encephalopathy, 42 | 2021-03-30 | criteria provided, single submitter | clinical testing | CACNA1A NM_001127222.1 exon 47 p.Ser2423_Gly2424del (c.7266_7271del): This variant has not been reported in the literature but is present in 0.2% (45/17222) of Latino alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs775428832). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. This variant represents an in-frame deletion of 2 amino acids at position 2423/2424 and is not predicted to alter the reading frame. However, the effect of this variant on the protein is unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Ce |
RCV003424326 | SCV004137964 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | CACNA1A: PM4, BS1 |
Prevention |
RCV003985425 | SCV004755895 | likely benign | CACNA1A-related disorder | 2019-07-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome |
RCV003227847 | SCV004804630 | not provided | Episodic ataxia type 2; Spinocerebellar ataxia type 6; Migraine, familial hemiplegic, 1; Developmental and epileptic encephalopathy, 42 | no assertion provided | phenotyping only | Variant classified as Uncertain significance and reported on 05-13-2021 by Vanderbilt University Medical Center. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Dr. Philip Payne from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/. |